Plain-English translation of NCT06511505 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The NOTABLE trial tests whether an AI tool that analyzes heart rhythm tests (called ECGs) can help doctors find heart problems that patients didn't know they had. Half of the study clinics will use this AI screening tool, while the other half will use regular care. The study will track whether the AI helps catch more heart conditions early and leads to better health outcomes for patients.
Many people have treatable heart conditions—like irregular heartbeats or valve problems—that go undiagnosed until they cause serious problems. This study is testing whether artificial intelligence can help doctors spot these hidden conditions sooner, so patients can get treatment before complications develop.
You likely qualify if…
You likely don't qualify if…
If you join this study, your doctor will order a regular heart rhythm test (ECG) as part of your routine care. Depending on which group you're randomly assigned to, your doctor may receive AI-powered recommendations suggesting follow-up heart tests if any warning signs are found. The study will track your health outcomes over time to see whether the AI screening leads to earlier diagnosis and better care. There are no extra visits or special procedures required beyond your normal medical care.
AI-generated summary from trial data · Aug 30, 2026 · Not medical advice
United States